Investor Relations
August 19, 2008
Fourth Annual Noble Financial Equity Conference
Listen to webcast
VIA (Nasdaq: VIAP) is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is building a pipeline of small molecule drugs that intervene directly in the chronic inflammation underlying atherosclerosis.
